Noxopharm Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.041; its P/E ratio is -1.49; Noxopharm Ltd. is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 14.01M	AU$ 26.80M	AU$ 7.10M	AU$ 2.91M	AU$ 12.61M
Total Assets	AU$ 26.59M	AU$ 47.85M	AU$ 20.07M	AU$ 4.30M	AU$ 14.55M
Total Debt	AU$ 160.62K	AU$ 349.31K	AU$ 5.00M	AU$ 3.93M	AU$ 3.28M
Net Debt	AU$ -13.85M	AU$ -26.45M	AU$ -2.10M	AU$ 1.02M	AU$ -9.33M
Total Liabilities	AU$ 2.48M	AU$ 7.08M	AU$ 7.19M	AU$ 5.75M	AU$ 4.40M
Stockholders Equity	AU$ 24.12M	AU$ 40.78M	AU$ 12.87M	AU$ -100.67K	AU$ 10.15M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Noxopharm Ltd. Earnings and Revenue History

Income Statement >

Noxopharm Ltd. Debt to Assets

Balance Sheet >

Noxopharm Ltd. Cash Flow

Cash Flow >

Noxopharm Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing